Skip to main content
DEINOVE logo

DEINOVE — Investor Relations & Filings

Ticker · ALDEI ISIN · FR0010879056 LEI · 969500BEJSRFER0F2K08 PA Professional, scientific and technical activities
Open in API
Filings indexed 300 across all filing types
Latest filing 2014-07-04 Share Issue/Capital Cha…
Country FR France
Listing PA ALDEI

About DEINOVE

https://www.deinove.com

DEINOVE is a biotechnology company that discovers, develops, and produces high-value compounds derived from rare bacteria and microorganisms, often referred to as 'microbial dark matter'. Leveraging a proprietary technology platform, the company harnesses the metabolic potential of extremophilic bacteria, such as Deinococcus, to create innovative solutions. Its primary applications are focused on developing novel bio-based active ingredients, including carotenoids, for the cosmetics sector, and discovering new antibiotics to address the global challenge of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Share Issue/Capital Change Classification · 1% confidence The document is explicitly titled "Communiqué de presse" (Press Release) and discusses the cancellation of a planned capital increase ("augmentation de capital"). This relates directly to financing activities and capital structure changes. The key event is the cancellation of a fundraising effort. According to the definitions, 'Capital/Financing Update' (CAP) covers updates on company fundraising or capital structure changes. While it is a press release, its core subject matter is financing, making CAP more specific than the general 'RPA' or 'RNS'. The document is not a full report (like 10-K or IR) but an announcement about a specific financial action.
2014-07-04 French
Rachat d'actions / Contrat de liquidité Information relative au contrat de liquidité
Regulatory Filings Classification · 1% confidence The document is titled "Bilan semestriel du contrat de liquidité DEINOVE confié à KEPLER CHEUVREUX" (Semi-annual balance sheet of the DEINOVE liquidity contract entrusted to KEPLER CHEUVREUX) and reports the status of shares and cash held under a liquidity agreement as of June 30, 2014. This type of regular update concerning the company's own shares held under a specific agreement (like a share buyback or liquidity management program) aligns best with the definition of 'Transaction in Own Shares' (POS). While it is a periodic report, it is not a full financial report (10-K or IR), nor is it a general dividend announcement (DIV). It specifically details the status of shares managed under a contract, which is a form of share transaction activity.
2014-07-04 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "Communiqué de presse" (Press Release) and discusses the extension of the subscription period for a capital increase ('AUGMENTATION DE CAPITAL'). It details the revised timeline for the offering, placement, and issuance of new shares. This content directly relates to fundraising and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a simple announcement of a report (RPA), but rather the primary announcement detailing the financing event itself.
2014-06-27 French
Communiqués de mise à disposition de documents / Modalités de mise à disposition de prospectus
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "Communiqué de presse" (Press Release) and announces the launch of a capital increase ("augmentation de capital") with a priority period and subsequent public offering/private placement. This activity directly relates to fundraising, financing activities, and changes in capital structure. According to the definitions, this aligns perfectly with the 'Capital/Financing Update' category (Code: CAP). Although it details the structure of the offering, it is the announcement itself, not a general regulatory filing (RNS) or a report (10-K, IR).
2014-06-24 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is a press release dated June 16, 2014, announcing that DEINOVE's automated genetic engineering platform, utilizing CAD4Bio software, is operational. It details technological advancements, quotes management (CEO and R&D Director), and provides company background and contact information. This type of announcement, focusing on operational milestones, technology updates, and general business progress, is typically classified as a general Regulatory Filing (RNS) or sometimes an Investor Presentation (IP) if it were a slide deck. However, since it is a news release announcing a development rather than a formal financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP, DIRS), and it doesn't explicitly announce the publication of a formal report (which would suggest RPA), the most appropriate general category for a non-standard, informational press release is Regulatory Filings (RNS). The length (5173 chars) is substantial enough that it is not just a brief announcement of an attachment.
2014-06-16 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Earnings Release Classification · 1% confidence The document is a press release dated June 16, 2014, from DEINOVE announcing positive results from the DEINOCHEM program, specifically related to exercising an exclusive license option for a patent from GENOPLANTE-VALOR concerning isoprenoid biosynthesis. It details scientific progress, strategic decisions (licensing), and mentions future financing plans. This type of announcement, focusing on operational milestones, strategic partnerships, and technology validation, is characteristic of an Earnings Release (ER) or a general corporate update. Since it is not a full financial report (10-K or IR), nor a transcript (CT), nor a formal regulatory filing like a DVA or DIRS, and it announces key operational and strategic news, it best fits the Earnings Release (ER) category, which often includes operational highlights alongside financial context, or potentially a Regulatory Filing (RNS) if it were purely informational. Given the focus on 'results' and strategic confirmation, ER is the closest fit among the specific operational/financial codes, although it is not strictly a quarterly earnings report. However, since it is a significant corporate announcement detailing business progress and strategic moves, and it is not a specific filing like a dividend notice or management change, it falls under the general category of corporate news release. In the absence of a specific 'Corporate News Release' code, and given that it announces key operational achievements that often accompany earnings, ER is plausible, but RNS (Regulatory Filings - fallback) is safer for non-standard announcements. Given the content is a detailed announcement of a major business development (licensing and scientific success), it is a significant corporate disclosure. I will classify it as a Regulatory Filing (RNS) as it is a general corporate announcement that doesn't fit the highly specific financial report codes, adhering to the fallback rule if a better fit isn't present. However, since it details operational results and strategic confirmation, ER is also a strong candidate if we interpret ER broadly as 'key results announcement'. Given the context of financial reporting databases, major operational updates are often grouped with ERs. I will lean towards ER as it announces 'résultats très satisfaisants' and strategic confirmation, which is the core function of an ER, even if not tied to a specific fiscal quarter reporting period. FY 2014
2014-06-16 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.